Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 7/2015

01-07-2015 | Letter to the Editor - Food for Thought

Diastolic dysfunction and endothelial dysfunction in systemic lupus erythematosus

Authors: Ali Yildiz, Serdar Soydinc

Published in: Rheumatology International | Issue 7/2015

Login to get access

Excerpt

With great interest we have read the recent article of Chin et al. [1] on the association of endothelial function and myocardial diastolic function in women with systemic lupus erythematosus (SLE) and normal radionuclide myocardial perfusion imaging (MPI). In their study, authors revealed normal diastolic function (E/e′ ≤ 8) and definite diastolic dysfunction with E/e′ > 13, respectively, in 61 and 5 % of patients. Authors reported that the brachial artery flow-mediated vasodilatation (FMD%) was associated with E/e′ independent of confounding factors as well. In our opinion, some points of this work are not sufficiently clear. …
Literature
1.
Chin CW, Chin CY, Ng MX, Le TT, Huang FQ, Fong KY, Thumboo J, Tan RS (2014) Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus. Rheumatol Int 34:1281–1285. doi:10.​1007/​s00296-014-2968-4 CrossRefPubMed
2.
Yokota S, Ottervanger JP, Mouden M, Timmer JR, Knollema S, Jager PL (2014) Prevalence, location, and extent of significant coronary artery disease in patients with normal myocardial perfusion imaging. J Nucl Cardiol 21:284–290. doi:10.​1007/​s12350-013-9837-5 CrossRefPubMed
3.
Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE, Karas RH (2001) Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 38:1843–1849CrossRefPubMed
4.
5.
Fukutomi M, Hoshide S, Mizuno H, Kario K (2014) Differential effects of aliskiren/amlodipine combination and high-dose amlodipine monotherapy on endothelial function in elderly hypertensive patients. Am J Hypertens 27:14–20. doi:10.​1093/​ajh/​hpt158 CrossRefPubMed
6.
Metadata
Title
Diastolic dysfunction and endothelial dysfunction in systemic lupus erythematosus
Authors
Ali Yildiz
Serdar Soydinc
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2015
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-015-3220-6

Other articles of this Issue 7/2015

Rheumatology International 7/2015 Go to the issue

Original Article - Clinical Trials

The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial

Review Article - Cases with a Message

Intracardiac thrombus in Behçet’s disease: four new cases and a comprehensive literature review

Original Article - Health Services Research

An early intervention program for subacute physical disability related to musculoskeletal diseases in the elderly: a pilot study

Review Article - Food for Thought

Fibrofog and fibromyalgia: a narrative review and implications for clinical practice

Original Article - Services Research

Labour force participation and the influence of having arthritis on financial status

Original Article - Genes and Disease

The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits